ArticleJournal of pain research2017

A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief).

Satoshi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.